Atlas Trials

Pulmonary Hypertension

655 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pulmonary Hypertension

RecordFirmDate
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) (NCT00325403)United Therapeutics2006-10-01
Placebo Controlled Trial of Bosentan in Scleroderma Patients (NCT00377455)Georgetown University2006-09-01
Investigation of Dysynchrony in Patients With Pulmonary Hypertension (NCT01571700)Stanford University2006-09-01
The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting (NCT00467896)Actelion2006-09-01
Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide (NCT02170519)Duke University2006-09-01
Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin (NCT00373360)United Therapeutics2006-09-01
Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension (NCT00323024)NITROX, LLC2006-09-01
Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension (NCT00380068)Gilead Sciences2006-08-01
Effect of Bosentan on Exercise Capacity at High Altitude (NCT00432978)VA Loma Linda Health Care System2006-07-01
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension (NCT00350844)Ann & Robert H Lurie Children's Hospital of Chicago2006-07-01
Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS) (NCT01062282)Bayer2006-07-01
Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria (NCT00367523)National Heart, Lung, and Blood Institute (NHLBI)2006-06-15
Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell Anemia (NCT00948012)Federal University of São Paulo2006-06-01
To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks (NCT00946114)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2006-06-01
Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension (NCT00314548)Aga Khan University2006-05-01
Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH) (NCT00313196)Actelion2006-04-01
Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH) (NCT00310830)Actelion2006-03-01
A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study (NCT00360087)Actelion2006-03-01
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management (NCT00370214)Actelion2006-03-01
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient (NCT00566137)Northwell Health2006-02-01
Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes (NCT07495774)Guangdong Provincial People's Hospital2006-01-04
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (NCT00319111)Actelion2006-01-01
Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure (NCT01156636)University of Milan2006-01-01
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia (NCT00270478)National Heart, Lung, and Blood Institute (NHLBI)2005-12-21
Simvastatin as a Treatment for Pulmonary Hypertension (NCT00180713)Imperial College London2005-10-01
Natrecor for Pulmonary Hypertension in Lung Transplants (NCT00205426)University of Wisconsin, Madison2005-08-01
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn (NCT00139217)Emory University2005-08-01
Using Health-related Quality of Life (HRQL) in Routine Clinical Care (NCT00457301)University of Alberta2005-07-01
Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension (NCT00173537)National Taiwan University Hospital2005-07-01
Pharmacogenomics in Pulmonary Arterial Hypertension (NCT00593905)West Penn Allegheny Health System2005-07-01
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) (NCT00147199)United Therapeutics2005-06-01
Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension (NCT00190333)Assistance Publique - Hôpitaux de Paris2005-06-01
Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension (NCT00423592)Gilead Sciences2005-05-01
Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery (NCT00235521)Heidelberg University2005-05-01
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis (NCT00109681)Actelion2005-04-01
Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery? (NCT00334490)Unity Health Toronto2005-03-01
A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension (NCT00850369)University of North Carolina, Chapel Hill2005-02-01
Losartan Therapy in Pulmonary Hypertension (NCT00519870)Baskent University2005-01-01
Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) (NCT00086463)Actelion2004-06-01
Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II (NCT00091715)Actelion2004-04-01
ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) (NCT00091598)Gilead Sciences2004-01-01
Sildenafil and Pulmonary Artery Pressure (NCT00145938)University of Chicago2003-09-01
The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH (NCT00159861)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2003-07-01
Vasoactive Intestinal Peptide in COPD (NCT00464932)Medical University of Vienna2003-06-01
Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension (NCT00080457)Encysive Pharmaceuticals2003-05-01
Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension (NCT00424021)Gilead Sciences2003-04-01
Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients (NCT01621971)Konkuk University Medical Center2003-01-01
Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension (NCT00159887)Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2002-12-01
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension (NCT00058929)United Therapeutics2002-10-01
Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension (NCT00046319)Gilead Sciences2002-09-01
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension (NCT00023296)National Heart, Lung, and Blood Institute (NHLBI)2001-07-27
Idiopathic Pre-capillary Pulmonary Hypertension in ESKD Patients (NCT02743091)Toujinkai Hospital2001-01-01
The Role of Endothelin in Pulmonary Hypertension (NCT00759408)Brigham and Women's Hospital1999-02-01
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension (NCT00004497)United Therapeutics1998-10-01
Giessen Pulmonary Hypertension Registry and Biobank (NCT04145024)University of Giessen1993-07-01
Evaluation of Patients With Known or Suspected Heart Disease (NCT00001313)National Heart, Lung, and Blood Institute (NHLBI)1992-05-10
Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death (NCT00004805)National Center for Research Resources (NCRR)1991-09-01
Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement (NCT04432545)Universidad de la Sabana
Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis (NCT05356052)Bellerophon
Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension (NCT00034307)ICOS-Texas Biotechnology
Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease (NCT05572996)Ferrer Internacional S.A.
← Previous Next →

Track Pulmonary Hypertension automatically

Every clearance here is in the API, with alerts when new ones post.